Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 2
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,238 | Dovepress* | 5,238+ | 1,676 | 6,914 | |
Totals | 5,238 | 1,676 | 6,914 | ||
*Since 15 November 2007 +Since July 2016 |
View citations on Google Scholar